seed
Stage
1
Investors
About
ToxoTech engineers next-generation botulinum neurotoxins to develop novel therapeutics that provide more precise, durable, and effective treatments for neuromuscular and neurological disorders.
Explore ToxoTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.